Fig. 4: Dynamics of individual tsRNAs and RS during therapy. | Blood Cancer Journal

Fig. 4: Dynamics of individual tsRNAs and RS during therapy.

From: A 6-tsRNA signature for early detection, treatment response monitoring, and prognosis prediction in diffuse large B cell lymphoma

Fig. 4

A–F The relative expression of tsRNA-Leu-AAG, tsRNA-Gln-CTG, tsRNA-Pro-CGG, tsRNA-Leu-CAG, tsRNA-Lys-CTT, and tsRNA-Cys-GCA at pre-treatment and cycle 2, day 1. G Comparison of interim response assessment in DLBCL patients with the early molecular response (EMR) and non-early molecular response (No-EMR) at cycle 2, day 1. H Kaplan–Meier estimated the overall survival of different groups based on EMR in the internal validation cohort.

Back to article page